Medicamen Biotech Limited — Results, 18-02-2025: Integrated Filing- Financial

Medicamen Biotech Limited's board meeting approved the unaudited financial results for the quarter and nine months ended December 31, 2024. Key highlights include the appointment of Mr. Chandan Kumar as Chief Financial Officer, bringing over 15 years of experience in accounting, taxation, and auditing. This leadership change may bolster financial management as the company navigates its operations. Investors may view this as a positive outlook, given the credentials of the new CFO, potentially enhancing confidence in the company's strategic direction and financial oversight. More details are available on their website.